TD Asset Management Inc

Position in GPCR — Structure Therapeutics Inc.

CIK 1056053 Toronto, A6

Position in GPCR

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$3,701,190

-$6,168,338 QoQ

Shares Held

68,962

-66.3% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 190 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,140,636,067 across 120 Biotechnology names. GPCR ranks #57 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,701,190	68,962	-66.3%	Shares	Sole	2026-08-04
2026-03-31	$9,869,528	204,762	+17.2%	Shares	Sole	2026-05-11
2025-12-31	$12,148,576	174,674	+384.0%	Shares	Sole	2026-02-10
2025-09-30	$1,010,408	36,086	-17.4%	Shares	Sole	2025-11-10
2025-06-30	$906,047	43,686	0.0%	Shares	Sole	2025-07-28
2025-03-31	$756,204	43,686	-50.8%	Shares	Sole	2025-05-07
2024-12-31	$2,410,479	88,882	-53.4%	Shares	Sole	2025-02-11
2024-09-30	$8,372,280	190,756	-9.8%	Shares	Sole	2024-11-01
2024-06-30	$8,309,139	211,590	+47.9%	Shares	Sole	2024-08-02
2024-03-31	$6,133,266	143,100	-9.0%	Shares	Sole	2024-05-08
2023-12-31	$6,409,836	157,258	+3.3%	Shares	Sole	2024-02-12
2023-09-30	$7,672,713	152,176	+109.3%	Shares	Sole	2023-10-27
2023-06-30	$3,022,513	72,709	+102.3%	Shares	Sole	2023-08-09
2023-03-31	$855,155	35,946	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.